临床风险分组解决方案市场 - 按组件（软体{私有和公共云端}、服务）、应用程式（人口健康、慢性病管理、临床决策支援）、最终用途（ASC、医院和诊所）、全球预测（2024 年-第2032章

Clinical Risk Grouping Solution Market - By Component (Software {Private & Public Cloud}, Service), Application (Population Health, Chronic Disease Management, Clinical Decision Support), End-use (ASC, Hospital & Clinic), Global Forecast (2024 - 2032)

出版日期: 2024年06月24日 | 出版商:

Global Market Insights Inc. | 英文 128 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于医疗保健系统中对有效风险管理和患者分层的需求不断增长，预计 2024 年至 2032 年间，临床风险分组解决方案市场规模的复合年增长率将达到 11.5%。由于医疗保健提供者专注于改善患者治疗结果和优化资源分配，因此临床风险分组解决方案有望为识别不良事件或併发症风险较高的患者提供有价值的工具。例如，2023 年 9 月，Reveleer 为风险承担提供者推出了两套新解决方案。

这些技术透过处理大量患者资料并识别传统方法可能不明显的模式，提高了风险评估的准确性和效率。这些解决方案与电子健康记录 (EHR) 和其他医疗保健 IT 系统的整合也提高了它们的实用性和可近性，从而简化了医疗保健提供者的风险管理流程。

整体产业成长分为组件、应用、最终用途和地区。

根据组成部分，服务领域的临床风险分组解决方案市场预计在 2024 年至 2032 年期间将显着成长。这是由于对实施和优化风险管理解决方案的全面支援和客製化。咨询、培训和持续技术支援等服务对于医疗保健组织有效地将临床风险分组解决方案整合到其现有工作流程并最大限度地提高其效益至关重要。

预计到 2032 年，慢性病管理应用领域的临床风险分组解决方案市场规模将大幅成长。临床风险分组解决方案对于识别糖尿病、心血管疾病和呼吸系统疾病等慢性疾病的高风险患者至关重要，使医疗保健提供者能够更准确地制定治疗计划和干预措施。

预计到 2032 年，亚太地区临床风险分组解决方案产业将大幅成长，这归因于医疗保健数位化的快速发展以及在医疗保健成本不断上涨的情况下对改善患者治疗结果的日益重视。随着多个亚太国家正在投资先进的医疗保健技术和电子病历，对临床风险分组解决方案的需求不断增长，以加强患者分层并优化护理服务。

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

3M Corporation
4S Dawn Clinical Software
Apixio
Cotiviti Inc.
Evolent
HBI Solutions
Health Catalyst, Inc.
HealthEC LLC
Lightbeam Health Solutions
MedeAnalytics, Inc.
Nuance Communications, Inc.
Optum, Inc.
RELX (LexisNexis Risk Solution)
ZeOmega

简介目录

Product Code: 9982

Clinical risk grouping solution market size is anticipated to witness 11.5% CAGR between 2024 and 2032 driven by the increasing need for effective risk management and patient stratification in healthcare systems. As healthcare providers are focusing on improving patient outcomes and optimizing resource allocation, clinical risk grouping solutions are favored to offer valuable tools for identifying patients at higher risk of adverse events or complications. For instance, in September 2023, Reveleer unveiled two new suites of solutions for risk-bearing providers.

These technologies are enhancing the accuracy and efficiency of risk assessments by processing vast amounts of patient data and identifying patterns that may not be apparent through traditional methods. The integration of these solutions with electronic health records (EHRs) and other healthcare IT systems is also improving their utility and accessibility for streamlining the risk management process for healthcare providers.

The overall industry growth is divided into component, application, end-use and region.

Based on component, the clinical risk grouping solution market from the services segment is slated to witness significant growth during 2024-2032. This is due to the comprehensive support and customization for implementing and optimizing risk management solutions. Services, such as consulting, training, and ongoing technical support are essential for healthcare organizations to effectively integrate clinical risk grouping solutions into their existing workflows and maximize their benefits.

Clinical risk grouping solution market size from the chronic disease management application segment will foresee considerable growth up to 2032. This is owing to the need for effective patient stratification and monitoring in managing long-term health conditions. Clinical risk grouping solutions are essential for identifying high-risk patients with chronic diseases, such as diabetes, cardiovascular disorders, and respiratory conditions, allowing healthcare providers to tailor treatment plans and interventions more precisely.

Asia Pacific clinical risk grouping solution industry is anticipated to witness substantial growth through 2032 attributed to rapid healthcare digitization and increasing emphasis on improving patient outcomes amidst rising healthcare costs. As several APAC countries are investing in advanced healthcare technologies and EHRs, there is growing demand for clinical risk grouping solutions to enhance patient stratification and optimize care delivery.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360º synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing healthcare cost
  - 3.2.1.2 Rise in the adoption of electronic health records (EHR)
  - 3.2.1.3 Increasing investment in healthcare IT
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Data security and privacy concerns
  - 3.2.2.2 Regulatory and legal challenges
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Software
- 5.2.1 Private cloud
- 5.2.2 Public cloud
- 5.2.3 Hybrid cloud
5.3 Services

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Population health management
6.3 Chronic disease management
6.4 Clinical decision support
6.5 Fraud detection and prevention
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals & clinics
7.3 Ambulatory surgical centers
7.4 Long term care centers
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa